Indical acquires Afosa to expand into the companion animal sector

November 24, 2020

Indical has acquired Afosa GmbH, a leading provider of ELISA diagnostics products to the companion animal sector, based in Germany.

Indical has a strong diagnostics portfolio focused on production animals, which is built on more than twenty years of research and development of molecular and immunological testing solutions. Through the acquisition of Afosa, Indical broadens its product offering to also include a number of diagnostic kits for companion animals.

Recent news

Fidelio becomes the new majority owner of Hemfrid…

Fidelio is excited about partnering with founder Monica Lindstedt, CEO Cecilia Tosting and the entire Hemfrid team on their continued growth journey. Since its foundation in 1996, Hemfrid has been a pioneer in an industry that makes everyday life easier.

Read more

First day of trading in Vimian’s shares on …

Vimian Group AB (publ) (“Vimian”, the “Group” or the “Company”), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, today announces the listing of and commencement

Read more

Vimian announces intention to list on Nasdaq Firs…

Vimian Group AB (publ), a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, announces its intention to carry out a private placement of shares in the

Read more